Philips pens 2 long-term equipment and consulting deals with German hospitals for over €140M

Austrian hotel group Vienna House has launched its newest brand, Vienna House R.evo.
Philips also signed an eight-year consultancy and equipment agreement with Munich Municipal Hospital worth $58.6 million. (Alejandro/CC BY 2.0)

Royal Philips signed long-term partnerships with two hospital groups in Germany, agreeing to help reform their radiology workflows and supply medical imaging equipment, including its IQon Spectral CT hardware.

The Kliniken der Stadt Köln, or Clinics of Cologne, and Philips signed a 15-year contract worth about €90 million ($105.4 million), with Philips being responsible for the delivery, upgrade, replacement and maintenance of its precision diagnosis and therapy systems.

Philips also signed an eight-year consultancy and equipment agreement with Munich Municipal Hospital worth €50 million ($58.6 million), the Amsterdam-based company said. Philips plans to help the hospital system phase in and renew over 200 imaging systems, as well as provide clinical informatics support.

Webinar

How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC

CROs are often at the forefront of adopting new technologies to make clinical trials more efficient. Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management.

“These partnerships underline Philips’ transition to becoming an integrated solutions provider that takes a holistic approach to meeting its customers’ needs,” Peter Vullinghs, CEO of Philips in Germany, Austria and Switzerland, said in a statement.

RELATED: Royal Philips acquires the U.K.’s Remote Diagnostic Technologies for undisclosed price

Under the Cologne agreement, Philips will help plan a new radiology unit, including the construction of a new building in Merheim, and help optimize operating procedures in radiology for children and adults. The deal covers all three of the clinic’s locations, in Holweide, Merheim and the Children’s Hospital Amsterdamer Strasse.

RELATED: Philips gets FDA nod for 2-in-1 imaging device

Meanwhile in Munich, Philips described the partnership as the largest medical technology project for a single clinic in Europe, with the goal of developing strategies for the municipal group to digitize its operations and connect care across its sites and medical disciplines.

“By combining innovative technology concepts that address the evolving needs of our patient population with continuous improvement of our processes, we aim to ensure cost-effective care for patients in the Munich region over the long-term,” said Axel Fischer, chairman of the board of management at the Munich system.

In addition, Philips will tackle departments’ designs and clinical processes to optimize planning and technology use, as well as aim to improve treatment outcomes and patient and staff experiences.

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.